CN Patent

CN105732355A — 1-(5-氟-2-碘苯基)乙酮的制备方法

Assigned to Medical Science And Technology (shanghai) Co Ltd · Expires 2016-07-06 · 10y expired

What this patent protects

本发明涉及1(5氟2碘苯基)乙酮的制备方法。本发明创造为将2氨基5氟苯甲酸与5氟2碘苯甲酸进行反应制备得到终产物1(5氟2碘苯基)乙酮。本发明创造方法简便，产物收率和纯度高，反应条件温和安全性高，特别适合工业化生产。

USPTO Abstract

本发明涉及1(5氟2碘苯基)乙酮的制备方法。本发明创造为将2氨基5氟苯甲酸与5氟2碘苯甲酸进行反应制备得到终产物1(5氟2碘苯基)乙酮。本发明创造方法简便，产物收率和纯度高，反应条件温和安全性高，特别适合工业化生产。

Drugs covered by this patent

Lorbrena (lorlatinib) · Pfizer

Patent Metadata

Patent number: CN105732355A
Jurisdiction: CN
Classification: —
Expires: 2016-07-06
Drug substance claim: No
Drug product claim: No
Assignee: Medical Science And Technology (shanghai) Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.